Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Penile Neoplasms × dacomitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 18 Neoplasm Metastasis 6 Carcinoma, Squamous Cell 4 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Brain Neoplasms 3 Recurrence 2 Neoplasms 2 Head and Neck Neoplasms 2 Glioblastoma 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Rare Tumor 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 NSCLC 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Cisplatin 6 Nivolumab 5 pembrolizumab 4 fludarabine 4 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Ifosfamide 4 Cyclophosphamide 4 aldesleukin 3 Ipilimumab 3 fludarabine phosphate 2 entinostat 2 cabozantinib 2 avelumab 2 aflibercept 2 Specimen Handling 2 Radiotherapy 2 CTLA-4 Antigen 2 vinflunine 1 toripalimab 1 ripretinib 1 oncogene protein E7, Human papillomavirus type 16 1 niraparib 1 nimotuzumab 1 enfortumab vedotin 1 dostarlimab 1 dacomitinib 1 cemiplimab 1 cabazitaxel 1 bintrafusp alfa protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01728233 2021-05-14

HER-Uro01

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed

Carcinoma, Squamous Cell, Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡